JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
Clinical trial NCT04720976 · COMPLETED
Trial details
- NCT number
- NCT04720976
- Sponsor
- Allist Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2023-12-19
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.